KR20140132778A - 정맥내 항바이러스 치료 - Google Patents

정맥내 항바이러스 치료 Download PDF

Info

Publication number
KR20140132778A
KR20140132778A KR20147030611A KR20147030611A KR20140132778A KR 20140132778 A KR20140132778 A KR 20140132778A KR 20147030611 A KR20147030611 A KR 20147030611A KR 20147030611 A KR20147030611 A KR 20147030611A KR 20140132778 A KR20140132778 A KR 20140132778A
Authority
KR
South Korea
Prior art keywords
certain embodiments
formula
compound
iii
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR20147030611A
Other languages
English (en)
Korean (ko)
Inventor
얄라가따 수타카라 바부
푸란 챈드
샨타 반티아
쉐인 아놀드
존 마이클 킬패트릭
Original Assignee
바이오크리스트 파마수티컬즈, 인코퍼레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38169715&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20140132778(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US2006/013535 external-priority patent/WO2007117241A1/en
Application filed by 바이오크리스트 파마수티컬즈, 인코퍼레이티드 filed Critical 바이오크리스트 파마수티컬즈, 인코퍼레이티드
Publication of KR20140132778A publication Critical patent/KR20140132778A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
KR20147030611A 2006-02-13 2007-02-12 정맥내 항바이러스 치료 Ceased KR20140132778A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US77274806P 2006-02-13 2006-02-13
US60/772,748 2006-02-13
PCT/US2006/013535 WO2007117241A1 (en) 2006-04-12 2006-04-12 Intramuscular antiviral treatments
USPCT/US2006/013535 2006-04-12
PCT/US2007/003755 WO2007095218A1 (en) 2006-02-13 2007-02-12 Intravenous antiviral treatments

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020087022406A Division KR20080096829A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020167030296A Division KR20160129105A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료

Publications (1)

Publication Number Publication Date
KR20140132778A true KR20140132778A (ko) 2014-11-18

Family

ID=38169715

Family Applications (9)

Application Number Title Priority Date Filing Date
KR20147030611A Ceased KR20140132778A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020227042429A Ceased KR20230003248A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020187005451A Ceased KR101992585B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020207036259A Active KR102267754B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020217035812A Active KR102475176B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020217018500A Active KR102323339B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020197017311A Active KR102194015B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020087022406A Ceased KR20080096829A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020167030296A Ceased KR20160129105A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료

Family Applications After (8)

Application Number Title Priority Date Filing Date
KR1020227042429A Ceased KR20230003248A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020187005451A Ceased KR101992585B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020207036259A Active KR102267754B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020217035812A Active KR102475176B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020217018500A Active KR102323339B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020197017311A Active KR102194015B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020087022406A Ceased KR20080096829A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020167030296A Ceased KR20160129105A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료

Country Status (11)

Country Link
EP (1) EP1986626A1 (https=)
JP (3) JP2009538822A (https=)
KR (9) KR20140132778A (https=)
AU (2) AU2007215156A1 (https=)
BR (1) BRPI0707769A2 (https=)
CA (1) CA2642260C (https=)
EA (1) EA025483B1 (https=)
HK (1) HK1212250A1 (https=)
MX (2) MX393640B (https=)
MY (1) MY166063A (https=)
WO (1) WO2007095218A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140132778A (ko) * 2006-02-13 2014-11-18 바이오크리스트 파마수티컬즈, 인코퍼레이티드 정맥내 항바이러스 치료
CN101367750B (zh) * 2007-08-14 2012-05-23 中国人民解放军军事医学科学院毒物药物研究所 (1s,2s,3s,4r)-3-[(1s)-1-乙酰氨-2-乙基-丁基]-4-胍基-2-羟基-环戊基-1-羧酸水合物及其医药用途
KR20220033561A (ko) 2020-09-07 2022-03-17 주식회사 경보제약 페라미비르 화합물을 포함하는 프리믹스 제형의 제약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT933993E (pt) * 1996-06-14 2006-10-31 Biocryst Pharm Inc Compostos de ciclopentano substituidos, uteis como inibidores de neuraminidase
DK1040094T3 (da) * 1997-12-17 2009-06-02 Biocryst Pharm Inc Substitueret cyklopentan og cyklopenten-forbindelser anvendelige som neuraminidase-inhibitorer
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
KR20140132778A (ko) * 2006-02-13 2014-11-18 바이오크리스트 파마수티컬즈, 인코퍼레이티드 정맥내 항바이러스 치료

Also Published As

Publication number Publication date
KR102267754B1 (ko) 2021-06-23
KR102194015B1 (ko) 2020-12-22
EA025483B1 (ru) 2016-12-30
MX2020002008A (es) 2020-07-13
EA200870263A1 (ru) 2009-06-30
KR20210076189A (ko) 2021-06-23
JP2009538822A (ja) 2009-11-12
KR20230003248A (ko) 2023-01-05
WO2007095218A1 (en) 2007-08-23
MX2008010394A (es) 2009-01-12
HK1212250A1 (en) 2016-06-10
CA2642260A1 (en) 2007-08-23
KR20160129105A (ko) 2016-11-08
KR101992585B9 (ko) 2022-09-20
KR20210135632A (ko) 2021-11-15
MY166063A (en) 2018-05-23
AU2013216632A1 (en) 2013-08-29
AU2013216632B2 (en) 2016-09-01
KR20200143519A (ko) 2020-12-23
MX393640B (es) 2025-03-21
KR102323339B1 (ko) 2021-11-08
EP1986626A1 (en) 2008-11-05
KR101992585B1 (ko) 2019-06-25
JP6073202B2 (ja) 2017-02-01
CA2642260C (en) 2016-08-09
KR20180024027A (ko) 2018-03-07
BRPI0707769A2 (pt) 2011-05-10
KR20080096829A (ko) 2008-11-03
JP2015180695A (ja) 2015-10-15
JP2013256527A (ja) 2013-12-26
KR20190072681A (ko) 2019-06-25
KR102475176B1 (ko) 2022-12-07
AU2007215156A1 (en) 2007-08-23

Similar Documents

Publication Publication Date Title
US12121503B2 (en) Antiviral treatments
KR101992585B1 (ko) 정맥내 항바이러스 치료
CN104784166A (zh) 抗病毒化合物、包含该化合物的剂型及其用途
JP2009538822A5 (https=)
AU2016262644A1 (en) Intravenous antiviral treatments
US20110015264A1 (en) Intramuscular antiviral treatments
KR20080113099A (ko) 근육내 항바이러스 치료
NZ570538A (en) Intravenous antiviral treatments

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20141030

Application number text: 1020087022406

Filing date: 20080912

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20141128

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20141218

Patent event code: PE09021S01D

E90F Notification of reason for final refusal
PE0902 Notice of grounds for rejection

Comment text: Final Notice of Reason for Refusal

Patent event date: 20151030

Patent event code: PE09021S02D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20160630

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20151030

Comment text: Final Notice of Reason for Refusal

Patent event code: PE06011S02I

Patent event date: 20141218

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20160928

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20160630

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20161031

Appeal identifier: 2016101005654

Request date: 20160928

A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20161028

Application number text: 1020087022406

Filing date: 20080912

J121 Written withdrawal of request for trial
PC1202 Submission of document of withdrawal before decision of registration

Comment text: [Withdrawal of Procedure relating to Patent, etc.] Withdrawal (Abandonment)

Patent event code: PC12021R01D

Patent event date: 20161031

PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20161031

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2016101005654

Request date: 20160928

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20161031

WITB Written withdrawal of application